{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:55:51Z","timestamp":1790949351194,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.mayocp.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T10:04:26Z","timestamp":1667297066000},"page":"2139-2144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Ischemic Stroke in Patients With Malignancy"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-7408","authenticated-orcid":false,"given":"Ugur","family":"Sener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-0874","authenticated-orcid":false,"given":"Zafer","family":"Keser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mayocp.2022.09.003_bib1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics \u2014 2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2022.09.003_bib2","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","article-title":"Management of acute ischemic stroke","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit Care Med"},{"issue":"15","key":"10.1016\/j.mayocp.2022.09.003_bib3","article-title":"Prevalence and overlap of potential embolic sources in patients with embolic stroke of undetermined source","volume":"8","author":"Ntaios","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.mayocp.2022.09.003_bib4","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.mayocp.2022.09.003_bib5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2022.09.003_bib6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"52","author":"Navi","year":"2021","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.mayocp.2022.09.003_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2018-06-860874","article-title":"Arterial thromboembolic events preceding the diagnosis of cancer in older persons","volume":"133","author":"Navi","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mayocp.2022.09.003_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ene.14172","article-title":"Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial","volume":"27","author":"Martinez-Majander","year":"2020","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib10","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1038\/s41467-019-13120-6","article-title":"Stroke among cancer patients","volume":"10","author":"Zaorsky","year":"2019","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.mayocp.2022.09.003_bib11","first-page":"779","article-title":"Cancer-associated stroke: pathophysiology, detection and management (review)","volume":"54","author":"Dardiotis","year":"2019","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.09.003_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident\u00a0cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib13","first-page":"1","article-title":"Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms","volume":"22","author":"Bang","year":"2020","journal-title":"J\u00a0Stroke"},{"issue":"10","key":"10.1016\/j.mayocp.2022.09.003_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment","volume":"10","author":"Abdol Razak","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.mayocp.2022.09.003_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/jnnp.2006.092940","article-title":"Ischaemic stroke with malignancy may often be caused by paradoxical embolism","volume":"77","author":"Iguchi","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib16","first-page":"1039","article-title":"Stroke and cancer \u2014 a complicated relationship","volume":"2","author":"Dearborn","year":"2014","journal-title":"J\u00a0Neurol Transl Neurosci"},{"key":"10.1016\/j.mayocp.2022.09.003_bib17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.12659\/MSM.893855","article-title":"Risk factors for embolism in cardiac myxoma: a retrospective analysis","volume":"21","author":"He","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.mayocp.2022.09.003_bib18","first-page":"1","article-title":"Sequelae and management of radiation vasculopathy in neurosurgical patients","author":"Twitchell","year":"2018","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.mayocp.2022.09.003_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/0883073812474843","article-title":"SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients","volume":"29","author":"Armstrong","year":"2014","journal-title":"J\u00a0Child Neurol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.09.003_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102484","article-title":"Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis","volume":"9","author":"Zuo","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mayocp.2022.09.003_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2042098612452291","article-title":"Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance","volume":"3","author":"Palumbo","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"7","key":"10.1016\/j.mayocp.2022.09.003_bib22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/01.WNL.0000140491.54664.50","article-title":"Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis","volume":"63","author":"Bushnell","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.mayocp.2022.09.003_bib23","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1161\/STROKEAHA.119.026143","article-title":"Cancer-related ischemic stroke has a distinct blood mRNA expression profile","volume":"50","author":"Navi","year":"2019","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00005792-198501000-00002","article-title":"Cerebrovascular complications in patients with cancer","volume":"64","author":"Graus","year":"1985","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.mayocp.2022.09.003_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22050","article-title":"Coagulopathy and embolic signal in cancer patients with ischemic stroke","volume":"68","author":"Seok","year":"2010","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.09.003_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/acn3.291","article-title":"Characteristics of cryptogenic stroke in cancer patients","volume":"3","author":"Gon","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0000000000000539","article-title":"Recurrent thromboembolic events after ischemic stroke in patients with cancer","volume":"83","author":"Navi","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.mcna.2020.08.019","article-title":"Approach to patients with unintentional weight loss","volume":"105","author":"Perera","year":"2021","journal-title":"Med Clin North Am"},{"issue":"8","key":"10.1016\/j.mayocp.2022.09.003_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1506623","article-title":"Screening for occult cancer in unprovoked venous thromboembolism","volume":"373","author":"Carrier","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.09.003_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000363068","article-title":"Radiation-induced carotid artery stenosis: a comprehensive review of the literature","volume":"2","author":"Xu","year":"2014","journal-title":"Interv Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.09.003_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaneurol.2017.4211","article-title":"Enoxaparin vs aspirin in patients with cancer and ischemic stroke: the TEACH pilot randomized clinical trial","volume":"75","author":"Navi","year":"2018","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.09.003_bib32","first-page":"77","article-title":"Hypercoagulability and mortality of patients with stroke and active cancer: the OASIS-CANCER study","volume":"19","author":"Lee","year":"2017","journal-title":"J\u00a0Stroke"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622005377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622005377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:57:00Z","timestamp":1706003820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622005377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0025619622005377"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.09.003","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic Stroke in Patients With Malignancy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}